Hot Flashes
📧 Sign up to get email alerts when something new happens for Hot Flashes.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Chinese Women Going Through Menopause [Phase 2]
This update reports the completion of a Phase 2 trial evaluating fezolinetant for reducing hot flashes in Chinese women going through menopa…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause (OASIS-2) [Phase 3]
Phase 3 trial update for elinzanetant in vasomotor symptoms associated with menopause; the OASIS-2 study has completed and results have been…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 26 Weeks in Women Who Have Been Through the Menopause [Phase 3]
Phase 3 trial evaluating elinzanetant for vasomotor symptoms (hot flashes) due to menopause has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women [NA]
A completed clinical trial sponsored by Bonafide Health evaluated the effect of a herbal dietary supplement on vasomotor symptoms in menopau…
-
CLINICAL_TRIALS trial_result · 2025-12-01Clinical Trial Update: A Study to Learn More About How Well Elinzanetant Works and How Safe it is for the Treatment of Vasomotor Symptoms (Hot Flashes) That Are Caused by Hormonal Changes Over 52 Weeks in Women Who Have Been Through the Menopause [Phase 3]
Phase 3 study to evaluate the efficacy and safety of Elinzanetant for menopause-related vasomotor symptoms (hot flashes) over 52 weeks. Resu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: A Mobile App for Hot Flashes and Sleep Disturbances [NA]
A completed Baylor University–led clinical trial evaluated a mobile app aimed at reducing hot flashes and improving sleep disturbances.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause [Phase 2]
Phase 2 study of NOE-115 in women with vasomotor symptoms due to menopause has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: A Mind-Body Intervention for Hot Flash Management [NA]
A completed clinical trial evaluated a mind-body intervention for hot flashes and postmenopausal symptoms, with results posted on 2025-06-05…
-
CLINICAL_TRIALS trial_result · 2025-01-31Clinical Trial Update: A Study to Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With Menopause [Phase 3]
Phase 3 study evaluating the safety and tolerability of fezolinetant for relief of vasomotor symptoms associated with menopause has complete…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Venlafaxine and Hypnosis or Focused Attention in Treating Patients with Hot Flashes [NA]
A completed clinical trial evaluating venlafaxine combined with hypnosis or focused attention for treating hot flashes in menopausal patient…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: A Study to Find the Best Dose of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause [Phase 2]
Phase 2 dose-finding study to identify the best dose of fezolinetant for treating hot flashes in menopausal women; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women [Phase 1]
A Phase 1 clinical trial update reports the completion of a study evaluating whether elinzanetant affects driving ability and brain function…
-
CLINICAL_TRIALS trial_result · 2024-01-02Clinical Trial Update: PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health [Phase 2]
Phase 2 trial update for PhytoSERM addressing menopausal hot flashes and potential brain health implications.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer [Phase 3]
Phase 3 trial evaluating hormone replacement therapy for hot flashes and vaginal symptoms in postmenopausal women on tamoxifen for breast ca…
-
CLINICAL_TRIALS trial_result · 2023-06-05Clinical Trial Update: Stellate Ganglion Block (SGB) For Women for Breast Cancer [Phase 2]
Phase 2 clinical trial update on Stellate Ganglion Block for hot flashes in women undergoing breast cancer treatment; study completed with r…
-
CLINICAL_TRIALS trial_result · 2023-05-23Clinical Trial Update: HIRREM Hot Flashes Study [NA]
Clinical trial update for the HIRREM hot flashes study shows completed status with posted results.
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: A Study of BAY3427080 (NT-814) in the Treatment of Moderate to Severe Post-menopausal Vasomotor Symptoms [Phase 2]
Phase 2 trial of BAY3427080 (NT-814) in moderate to severe post-menopausal vasomotor symptoms completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: (SGB) in Men Treated for Prostate Cancer Improve Hot Flashes [Phase 4]
Phase 4 trial update showing improvement in hot flashes for men treated for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Reducing the Experience of Menopausal Symptoms Through Temperature [NA]
A completed clinical trial investigating the reduction of menopausal hot flashes using a temperature-based intervention; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2022-06-03Clinical Trial Update: Effects of Stellate Ganglion Block on Hot Flashes in Hispanic Women With Breast Cancer [Phase 2]
Phase 2 clinical trial investigating stellate ganglion block for hot flashes in Hispanic women with breast cancer; status terminated with re…
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: A Study to Evaluate the Effects of RCN3028 on Moderate to Severe Vasomotor Symptoms in Women [Phase 2]
Phase 2 study assessing the effects of RCN3028 on moderate to severe vasomotor symptoms in women has completed.
-
CLINICAL_TRIALS trial_result · 2022-01-11Clinical Trial Update: Phase 2 Study of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms [Phase 2]
A Phase 2 trial of SJX-653 in postmenopausal women with hot flashes has been terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-01-06Clinical Trial Update: Comparative Study to Evaluate the Efficacy and Safety of the Fixed-dose Combination of Estradiol / Dydrogesterone in Perimenopausal Women [Phase 4]
A phase 4 clinical trial evaluating the efficacy and safety of a fixed-dose combination of estradiol and dydrogesterone in perimenopausal wo…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes) [Phase 2]
Phase 2 dose-ranging study evaluating ESN364 for vasomotor symptoms (hot flashes) in postmenopausal women has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2020-12-07Clinical Trial Update: Research Investigation of Soy and Estrogen [Phase 2]
Phase 2 trial investigating soy and estrogen for menopause-related symptoms; study completed with results posted.